Breast Cancer: Targets and Therapy
eISSN: 1179-1314pISSN: 1179-1314
Open AccessShare this on:
Key Metrics
CiteScore 
5
SJR
Q1Oncology
SNIP
1
Topics Covered
Breast cancer
Overall survival
Metastatic breast cancer
Cross-sectional study
Breast cancer screening
Trastuzumab
Triple-negative breast cancer
Pathological response
Molecular pathology
Quality of life
Mastectomy
Ataxia telangiectasia mutated
Breast cancer cells
Eribulin
Hormone therapy
Progesterone receptor
Axillary ultrasound
Standard therapy
Immunohistochemistry
Breast examination
Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
Web of Science
Overview
- PublisherDove Medical Press
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 2320
- Publication Time16
- Editorial Review ProcessBlind peer review
General Details
- LanguageEnglish
- FrequencyContinuous publication
- Publication Start Year2009
- Publisher URL
- Website URL
Publication Details
- Plagiarism
- Publication Time16
- Waiver Policy
Editorial Review Detail
- Editorial Team
- Review ProcessBlind peer review
- Review Url
- Author instructions
- Copyright Details
- Deposit PolicySherpa/Romeo
- License typeCC BY, CC BY-NC
- OA statement
View less
Planning to publish in Breast Cancer: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers
Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
MiR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
Ovo Like Zinc Finger 2 (OVOL2) Suppresses Breast Cancer Stem Cell Traits and Correlates with Immune Cells Infiltration.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
MiR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
A Scoping Review on the Status of Female Breast Cancer in Asia with a Special Focus on Nepal.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer.
- 1 Jan 2022
- Breast cancer (Dove Medical Press)
FAQs
How long has Breast Cancer: Targets and Therapy been actively publishing? 
Breast Cancer: Targets and Therapy has been in operation since 2009 till date.
What is the publishing frequency of Breast Cancer: Targets and Therapy?
Breast Cancer: Targets and Therapy published with a Continuous publication frequency.
How many articles did Breast Cancer: Targets and Therapy publish last year?
In 2022, Breast Cancer: Targets and Therapy publsihed 13 articles.
What is the eISSN & pISSN for Breast Cancer: Targets and Therapy?
For Breast Cancer: Targets and Therapy, eISSN is 1179-1314 and pISSN is 1179-1314.
What is Citescore for Breast Cancer: Targets and Therapy?
Citescore for Breast Cancer: Targets and Therapy is 5.
What is SNIP score for Breast Cancer: Targets and Therapy?
SNIP score for Breast Cancer: Targets and Therapy is 1.
What is the SJR for Breast Cancer: Targets and Therapy?
SJR for Breast Cancer: Targets and Therapy is Q1.
Who is the publisher of Breast Cancer: Targets and Therapy?
Dove Medical Press is the publisher of Breast Cancer: Targets and Therapy.